Time To Buy The Dip In Kenvue Stock?

Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty ImagesSOPA Images/LightRocket via Getty ImagesKenvue (NYSE:KVUE), the consumer healthcare spin-off from Johnson & Johnson, has experienced a significant decline in its stock price in recent months. The shares are currently priced around $15, which is more than 65% lower than their highs in 2023, as investors contend with legal uncertainties, management changes, and slowing sales growth. The question is whether this decline represents a wo ...